Previous studies reported that berbamine, the lead compound of BBD24, suppressed the expression of multidrug-resistance protein (MDR1) and Bcl-2 in K562 leukemia cells [42], caused depolarization of the mitochondrial membrane and decreased the membrane potential of HepG2 tumor cells [43]. This evidence concerns the gene BCL2 and neoplasm.